MYC and cancer: The expression of HIF-2α is significantly enhanced in several cancers [32,33,34], and can increase cancer stem-like properties by activating Wnt and Notch pathways and stem cell related markers such as c-Myc, octamer-binding transcription factor 4 (Oct4) and Nanog [35].